Ventyx Biosciences Inc (VTYX)
2.31
-0.05
(-2.12%)
USD |
NASDAQ |
Sep 27, 16:00
2.32
+0.01
(+0.43%)
After-Hours: 20:00
Ventyx Biosciences Research and Development Expense (Annual): 175.77M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 175.77M |
| December 31, 2022 | 87.74M |
| December 31, 2021 | 58.48M |
| Date | Value |
|---|---|
| December 31, 2020 | 6.366M |
| December 31, 2019 | 3.552M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
3.552M
Minimum
2019
175.77M
Maximum
2023
66.38M
Average
58.48M
Median
2021
Research and Development Expense (Annual) Benchmarks
| Pfizer Inc | 10.68B |
| Altimmune Inc | 65.80M |
| Viking Therapeutics Inc | 63.81M |
| vTv Therapeutics Inc | 13.60M |
| Structure Therapeutics Inc | 70.10M |